A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma

NCT01058863 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Albuterol Spiromax®
DRUG: ProAir® HFA
OTHER: Placebo Inhaler

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.